Sensory Neuropathy of the Foot Among Asymptomatic Patients of Type II Diabetes Mellitus
Keywords:
Asymptomatic Patients, foot, Peripheral Neuropathy, Sedentary Lifestyles, Sensory Neuropathy, Type II Diabetes MellitusAbstract
OBJECTIVE: This Study aimed to determine the frequency of sensory neuropathy in the feet of asymptomatic people with type II diabetes mellitus.
METHODOLOGY: This cross-sectional Study was conducted at the medical department of MTI/Lady Reading Hospital, Peshawar, between April - October 2022. A total of 133 patients were observed using a non-probability consecutive sampling technique. Patients aged 25-60 years who had type II diabetes mellitus for more than one year were included, while patients with vitamin B12 deficiency who used multivitamins were excluded from the study. SPSS version 20 was used for statistical analysis.
RESULTS: Age-wise distribution 25-30 Years (4.5%), 31-40 Years (21.8%), 41-50 Years (45.9%), and 51-60 Years (27.8%) (mean 45.56±3.3). Gender-wise, 104 (78.2%) were male and 29 (21.8%) were female. Regarding education level, 57 (42.9%) were illiterate, 46 (34.6%) had secondary education, and 30 (22.6%) had higher education. Residency status indicated 105 (78.9%) from urban areas and 28 (21.1%) from rural areas. Socioeconomic status was distributed as follows: 53 (39.8%) with a monthly income >100,000 Rs, 46 (34.6%) with an income range of 50,000 to 100,000 Rs, and 34 (25.6%) with an income range <50,000 Rs. Sensory neuropathy was found in 60 (45.1%) patients and absent in 73 (54.9%).
CONCLUSION: The Study revealed a notably high prevalence of sensory neuropathy. Prompt identification and focused treatment are essential, especially for patients over 40, sedentary lifestyles, and those with diabetes for more than two years.
References
Jha BK, Sherpa ML, Imran M, Yousuf M, Jha LA, Paudel KR et al. Progress in understanding metabolic syndrome and knowledge of its complex pathophysiology. Diabetology. 2023; 4(2): 134-59. doi: 10.3390/diabetology4020015.
Khan MAB, Hashim MJ, Hashim MJ, King JK, Govender RD, Mustafa H et al. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020; 10(1): 107-111. doi: 10.2991/jegh.k.191028.001.
Basiri R, Seidu B, Rudich M. Exploring the interrelationships between diabetes, nutrition, anxiety, and depression: Implications for treatment and prevention strategies. Nutrients. 2023; 15(19): 4226. doi: 10.3390/nu15194226.
Jyotsna F, Ahmed A, Kumar K. Exploring the complex connection between diabetes and cardiovascular disease: Analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus. 2023; 15(8): e43882. doi: 10.7759/cureus.43882.
Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019; 19(10): 86. doi: 10.1007/s11892-019-1212-8.
Aleidan FAS, Ahmad BA, Alotaibi FA. Prevalence and risk factors for diabetic peripheral neuropathy among Saudi hospitalized diabetic patients: A nested case-control study. Int J Gen Med. 2020; 13: 881-9. doi: 10.2147/ijgm.S273807.
Agunloye OM, Oboh G. Blood glucose lowering and effect of oyster (Pleurotus ostreatus)?and shiitake (Lentinus subnudus)?supplemented diet on key enzymes linked diabetes and hypertension in streptozotocin?induced diabetic in rats. Food Frontiers. 2022; 3: 161-71.
Sacchetta L, Chiriacò M, Nesti L, Leonetti S, Forotti G, Natali A et al. Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: A 21-year longitudinal study. Cardiovasc Diabetol. 2022; 21(1): 233. doi: 10.1186/s12933-022-01675-6.
Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan: A silent killer. Ann Med Surg (London). 2022; 79: 103901. doi: 10.1016/j.amsu.2022.103901.
Saeedi P, Petersohn I, Salpea P. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 2019; 157: 107843. doi: 10.1016/j.diabres.2019.107843.
Sambyal N, Saini P, Syal R. A review of statistical and machine learning techniques for microvascular complications in type 2 diabetes. Curr Diabetes Rev. 2021; 17(2): 143-55. doi: 10.2174/1573399816666200511003357.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019; 5(1): 41. doi: 10.1038/s41572-019-0097-9.
Carmichael J, Fadavi H, Ishibashi F, Shore AC, Tavakoli M. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol (Lausanne). 2021; 12: 671257. doi: 10.3389/ fendo.2021.671257.
Chang MC, Yang S. Diabetic peripheral neuropathy essentials: A narrative review. Ann Palliat Med. 2023; 12(2): 390-8. doi: 10.21037/apm-22-693. Epub 2023 Feb 8.
Akter N. Diabetic peripheral neuropathy: Epidemiology, physiopathology, diagnosis and treatment. Delta Med Coll J. 2019; 7(1): 35-48.
Sloan G, Shillo P, Selvarajah D, Wu J, WiliknsonLD, Tracey I et al. A new look at painful diabetic neuropathy. Diabetes Res Clin Pract. 2018; 144: 177-91. doi: 10.1016/j.diabres.2018.08.020. Epub 2018 Sep 7.
Azmi S, ElHadd KT, Nelson A, Chapman A, Bowling FL, Perumbalath A et al. Pregabalin in the management of painful diabetic neuropathy: A narrative review. Diabetes Ther. 2019; 10(1): 35-56. doi: 10.1007/s13300-018-0550-x.
Yang H, Sloan G, Ye Y, Wang S, Duan B, Tesfaye S et al. New perspective in diabetic neuropathy: From the periphery to the brain, a call for early detection, and precision medicine. Front Endocrinol (Lausanne). 2020; 10: 929. doi: 10.3389/fendo.2019.00929.
India State-level Disease Burden Initiative CRD Collaborators. The burden of respiratory diseases and their heterogeneity across the states of India: The Global burden of Disease study 1990-2016. Lancet Glob Health. 2018; 6(12): e1363-e74. doi: 10.1016/s2214-109x(18)30409-1.
Ghammari F, Khodayari-zarnaq R, Jalilian H, Gholizadeh M. Barriers to health care utilization among patients with type 2 diabetes living in slums: A qualitative study from providers' perspective. Glob Health Res Policy. 2023; 8(1): 13. doi: 10.1186/s41256-023-00296-0.
Ponirakis G, Elhadd T, Al Ozairi E, Brema I, Chinnaiyan S, Taghadom E et al. Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region. J Diabetes Investig. 2022; 13(9): 1551-9. doi: 10.1111/jdi.13815.
Syed O, Jancic P, Knezevic NN. A review of recent pharmacological advances in the management of diabetes-associated peripheral neuropathy. Pharmaceuticals (Basel). 2023; 16(6): 801. doi: 10.3390/ph16060801.
Laios K, Karamanou M, Saridaki Z, Androutsos G. Aretaeus of Cappadocia and the first description of diabetes. Hormones (Athens). 2012; 11(1): 109-13. doi: 10.1007/bf03401545.
Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod. 2005; 20(9): 2409-13. doi: 10.1093/humrep/dei100.
Abdissa D, Hamba N, Kene K. Prevalence and determinants of peripheral neuropathy among type 2 adult diabetes patients attending Jimma University Medical Center, Southwest Ethiopia, 2019, an Institutional-Based Cross-Sectional Study. J Diabetes Res. 2020; 2020: 9562920. doi: doi: 10.1155/ 2020/ 9562920.
Imam SK, Shahid SK, Hassan A, Alvi Z. Frequency of the metabolic syndrome in type 2 diabetic subjects attending the diabetes clinic of a tertiary care hospital. J Pak Med Assoc. 2007; 57(5): 239-42.
Fawwad A, Qasim R, Hydrie MZ. Correlation of fasting insulin resistance indices, clinical parameters of metabolic syndrome in type 2 diabetics. Pak J Med Sci. 2006; 22(4): 433-7.
Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA. 2002; 287(19): 2570-81. doi: 10.1001/jama.287.19.2570.
Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003; 46(6): 760-5. doi: 10.1007/s00125-003-1116-6.
Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS. The effect of intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes. Diabetes Care. 2007; 30(8): 2107-12. doi: 10.2337/dc06-1441.
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American diabetes association. Diabetes Care. 2007; 30(1): 162-72. doi: 10.2337/dc07-9917.
Liu M, Gao Y, Chen D-W, Lin S, Wang C, Chen L-H et al. Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes? J Diabetes Investig. 2021; 12(9): 1663-70. doi: 10.1111/jdi.13515.
Henriksen MG, Nordgaard J, Jansson LB. Genetics of schizophrenia: Overview of methods, findings and limitations. Front Hum Neurosci. 2017; 11: 322. doi: 10.3389/fnhum.2017.00322.
Qiao Q, DECODE Study Group. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia. 2006; 49(12): 2837-46. doi: 10.1007/s00125-006-0438-6.
Avogaro A, Giorda C, Maggini M, Munnucci E, Raschetti R, Lombardo F et al. Incidence of coronary heart disease in type 2 diabetic men and women: Impact of microvascular complications, treatment, and geographic location. Diabetes Care. 2007; 30(5): 1241-7. doi: 10.2337/dc06-2558.
Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006; 29(8): 1963-72. doi: 10.2337/dc06-9912.
Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351(26): 2683-93. doi: 10.1056/NEJMoa035622.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
